Use of anti-human integrin alpha D antibodies to treat spinal cord injury

Details for Australian Patent Application No. 2001296839 (hide)

Owner ICOS Corporation

Inventors Gallatin, W. Michael; Van Der Vieren, Monica

Agent Wrays

Pub. Number AU-B-2001296839

PCT Pub. Number WO02/30980

Priority 09/688,307 13.10.00 US

Filing date 15 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 3 April 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

Event Publications

3 April 2008 Application Accepted

  Published as AU-B-2001296839

31 July 2008 Standard Patent Sealed

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001296840-Fluid dispensing closure

2001296838-Systems and methods for monitoring arthropods